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Most cancer cells release heterogeneous popula-
tions of extracellular vesicles (EVs) containing pro-
teins, lipids, and nucleic acids. In vitro experiments
showed that EV uptake can lead to transfer of func-
tional mRNA and altered cellular behavior. However,
similar in vivo experiments remain challenging
because cells that take up EVs cannot be discrimi-
nated from non-EV-receiving cells. Here, we used
the Cre-LoxP system to directly identify tumor cells
that take up EVs in vivo. We show that EVs released
by malignant tumor cells are taken up by less malig-
nant tumor cells located within the same and within
distant tumors and that these EVs carry mRNAs
involved in migration and metastasis. By intravital
imaging, we show that the less malignant tumor
cells that take up EVs display enhanced migratory
behavior and metastatic capacity. We postulate
that tumor cells locally and systemically share mole-
cules carried by EVs in vivo and that this affects
cellular behavior.
INTRODUCTION
The heterogeneous nature of tumors dramatically complicates
the successful treatment of cancer (Meacham and Morrison,
2013). Tumors display intratumoral heterogeneity as a conse-
quence of genetic differences between individual cells. Together
with the diverging microenvironment surrounding tumor cells,
this leads to intercellular differences in epigenetic profiles and,
subsequently, to differential cellular behavior (Bissell and Hines,
2011; Postovit et al., 2006). The tumor microenvironment con-
sists of cells, soluble factors such as growth factors, and non-1046 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorssoluble factors, including the extracellular matrix (Joyce and
Pollard, 2009). A growing number of studies suggest that
extracellular vesicles (EVs) may also be an important microenvi-
ronmental factor (Raposo and Stoorvogel, 2013) that could
potentially affect tumor heterogeneity. Many different cell types
have been shown to transfer biomolecules, including proteins,
lipids, and nucleic acids, through the release and uptake of
EVs (Raposo and Stoorvogel, 2013). In vitro assays showed
that EV cargo, such as mRNA, is functional in cells that take up
EVs (Valadi et al., 2007), leading to behavioral changes of recip-
ient cells (Ratajczak et al., 2006; Salomon et al., 2013). Tumor
cells also release a wide variety of EVs (Bobrie and The´ry,
2013; The´ry et al., 2009), the cargo of which can potentially be
used as biomarkers (Balaj et al., 2011; D’Souza-Schorey and
Clancy, 2012; Skog et al., 2008). The cargo of EVs isolated
from tumor cell culture media can be bioactive because injection
of concentrated tumor-cell-line-derived EVs educates tumor-
supporting cells, such as bone-marrow-derived cells, that
subsequently prepare sentinel lymph nodes and lungs formetas-
tasis (Hood et al., 2011; Peinado et al., 2012). Vice versa, EVs
from stromal cells—for example, fibroblasts and activated
T cells—have been shown to alter the protrusive and migratory
behavior of tumor cells (Cai et al., 2012; Luga et al., 2012).
EV exchange between tumor cells in heterogeneous tumors
could potentially dramatically accelerate tumor progression if
highly metastatic cells spread their malignant behavior to less
malignant cells. However, acquiring direct evidence for the ex-
change of active biomolecules between tumor cells in vivo so
far remained challenging due to many technical limitations
(Raposo and Stoorvogel, 2013; The´ry, 2011). First, in vivo tumor
cells are exposed to EVs released by various cell types, making it
impossible to specifically measure the effect of tumor-derived
EVs on other tumor cells. To address this, concentrated EV prep-
arations isolated from cancer cell culture supernatants have
been injected into animal models. However, this does not reflect
the location, concentration, and continuous nature of EV release
by tumor cells in their in vivo setting. Second, techniques have
been lacking to directly track and study cells that take up in-
vivo-released tumor EVs and to compare their behavior to coun-
terparts that did not take up tumor-released EVs. Therefore, it is
unknown whether, in heterogeneous tumors in living mice, cells
with high metastatic potential can transfer biomaterial to less
metastatic cells, thereby influencing tumor progression.
Here, we combine high-resolution intravital imaging with a Cre
recombinase-based method to study EV exchange between
tumor cells. To show the spread of metastatic behavior through
EVs in living mice, we directly visualized the release of EVs by
highly metastatic human MDA-MB-231 mammary tumor cells.
Moreover, in living mice, we identified and studied the behavior
of less malignant human T47D mammary tumor cells that take
up these in-vivo-released EVs by more malignant MDA-MB-
231 cells. Our study illustrates that tumor heterogeneity contains
an additional layer of complexity with tumor cells sharing biomol-
ecules through local and systemic transfer of EVs, which pro-
foundly affects cell behavior.
RESULTS AND DISCUSSION
TumorCells Release aHeterogeneousPopulation of EVs
In Vivo
To examine the in vivo release of EVs by highly metastatic tumor
cells, we orthotopically transplanted MDA-MB-231 cells in the
mammary glands of mice, leading to the formation of highly met-
astatic mammary tumors. Next, we examined sections of these
tumors using confocal microscopy. As expected, we observed
EVs with a wide variety of sizes (Figure 1A). Next, to further
analyze the in vivo release of these EVs, we intravitally imaged
similar mammary tumors consisting of differently labeled MDA-
MB-231 cells (Figure 1B). We observed the release of EVs with
a diameter of 2.5 mm and smaller (Figure 1B and Movie S1, S2,
and S3). Because the resolution of a multiphoton microscope
is one order of magnitude smaller than the size of EVs such as
exosomes (500 versus 50 nm, respectively), the signal of small
EVs will be blurred to an area according to the microscope’s
point spread function (>1 mm diameter). To characterize the het-
erogeneous mixture of EVs, including plasma membrane-shed
vesicles and exosomes, we isolated EVs from MDA-MB-231
tumors as confirmed by electron microscopy (Figure 1C) and
determined the size distribution by nanoparticle tracking
analysis (NanoSight) (Figure 1D). Next, to identify potentially
functional EV cargo, we took the cells and EVs from tumors
and isolated their mRNA. We identified the differential mRNA
profile using gene expression arrays (Figure 1E) and found a sig-
nificant enrichment of mRNA molecules from >200 genes in EVs
compared to the cells (red dots Figure 1E and Table S1). Gene
ontology analysis showed that many of these enriched mRNA
molecules are involved in migration and metastasis (indicated
in red in Figure 1F and Table S2), both of which promote tumor
progression. Which mRNAs carried by EVs are critical for induc-
tion of behavioral changes of recipient cells depends on the
expression profile of the recipient cell. The mRNAs enriched in
EVs released by MDA-MB-231 cells may change the behavior
of MDA-MB-231 cells that take up these EVs due to the
abundance of mRNAs involved in metastasis. However, mRNAsfrom MDA-MB-231 cells that are not vesicular enriched but
abundantly present may induce behavioral changes when the
mRNA level of those particular genes is low in other recipient
cell types. This also holds true for other potentially functional bio-
molecules loaded in EVs such as DNA, (signaling) proteins,
lipids, and microRNAs (Raposo and Stoorvogel, 2013). There-
fore, it is important to realize that our data do not point to individ-
ual biomolecules that induce phenotypic changes in recipient
cells but illustrate that, within the tumor microenvironment, a
heterogeneous population of EVs is present containing biomole-
cules, among which there are mRNAs that are involved in migra-
tion and metastasis.
The Cre/LoxP System Can Be Used to Study EV Uptake
To study EV exchange in vivo, we utilized theCre-LoxP system to
induce a color switch specifically in reporter-expressing cells (re-
porter+) that take up EVs released from cells expressing the Cre
recombinase (Cre) (Cre+ cells) (Figure 2A). This Cre-LoxP system
uses the reverse approach of rendering donor cells vesiculation
deficient; recipient cells that do not take up EVs are marked with
DsRed (i.e., unrecombined reporter) and serve as an internal
control for eGFP-expressing recipient cells that have taken up
EVs. Importantly, the detection is restricted to uptake of EVs
released by Cre+ cells. This enables the analysis of biological ef-
fects induced by EVs released from an a priori defined tumor cell
population in vivo.
To study EV exchange using the Cre-LoxP system, we gener-
ated a MDA-MB-231 cell line expressing CFP and Cre. We
isolated EVs released from this Cre+ cell line, as confirmed by
electronmicroscopy (Figure 2B), and determined their size distri-
bution (Figure 2C). Importantly, tumor cells were able to take up
purified and fluorescently labeled EVs in vitro (Figure 2D and
Movie S4). Next, by western blot analysis, we confirmed that
the EVs contained the typical EV markers CD63 and Hsp70.
Although Cre protein was undetectable (Figure 2E) in EVs, Cre
mRNA was readily detected by RT-PCR (Figure 2F). Thus, Cre
mRNA molecules are incorporated into EVs that can be taken
up by tumor cells.
In order to determine whether Cre fromCFP+ Cre+ cells can be
functionally transferred to reporter+ cells, we co-cultured MDA-
MB-231 Cre+ and reporter+ cells for 1 week. In co-cultures of
Cre+ cells and reporter+ cells, converted eGFP+ reporter+ cells
appeared (Figure 3A), and the percentage of cells that switched
color increased with the ratio of Cre+ cells over reporter+ cells
(Figure 3B). Importantly, nearly all eGFP+ cells were negative
for CFP, excluding the possibility that cell fusion between Cre+
and reporter+ cells, rather than EV transfer, causes the appear-
ance of eGFP+ cells (Figure 3C). To further investigate cell-cell
contact-independent biomolecule transfer as a mechanism of
functional Cre transfer, we used transwell co-cultures that pre-
clude passage of Cre+ cells but allow passage of Cre+ EVs.
Indeed, seeding of Cre+ cells in the top well led to the appear-
ance of eGFP+ reporter+ cells in the lower well (Figure 3D, bot-
tom). To study whether malignant MDA-MB-231 cells can also
transfer Cre to other, less malignant, tumor cells, we generated
T47D and MCF-7 reporter+ cells. Interestingly, Cre was also
transferred from malignant to these less malignant cells in a
cell-cell contact-independent manner (Figure 3D, middle andCell 161, 1046–1057, May 21, 2015 ª2015 The Authors 1047
Figure 1. In Vivo Visualization of EV Release
andCharacterization of themRNAEVCargo
(A) Images of MDA-MB-231 tumor sections.
Boxed areas are shown on the right. Arrows point
to different EVs. Images were gamma adjusted to
also show dim and small EVs. Scale bars repre-
sent 10 mm (left image) and 1 mm (middle and right
image).
(B) Stills from intravital imaging movies (Movies
S1, S2, and S3) of MDA-MB-231 tumors where
CFP-marked MDA-MB-231 cells surrounded by
DsRed-marked cells release EVs (marked by cir-
cles). Images are maximum projections of 5 z
planes with a total z volume of 25 mm. Scale bars
represent 10 mm.
(C) Electron microscopy image of EVs isolated
from MDA-MB-231 tumors. Scale bar represents
500 nm.
(D) NanoSight particle analysis displaying the size
distribution of EVs isolated from MDA-MB-231
tumors. Black line represents mean of five exper-
iments, SD in gray.
(E) mRNA profile of EVs and cells isolated from
MDA-MB-231 tumors. Smoothed color density
representation shows RNA levels of whole cells
versus RNA derived from EVs. Red dots represent
genes that are significantly and more than 2-fold
enriched in EVs; significance is based on replicate
experiments (n = 6).
(F) These genes in (D) were used as input for
WebGestalt analysis (Wang et al., 2013). Bar plot
representation of p values from a gene ontology
enrichment analysis. Biological processes
involved in cell movement are shown in red.
See also Movies S1, S2, and S3 and Tables S1
and S2.right) and concentration-dependent manner (Figure 3E). These
data suggest that, in vitro, tumor cells with a high metastatic po-
tential can functionally transfer biomolecules (e.g., Cre) to less
malignant cells that could potentially affect their physiology.
Tumor Cells Take Up Tumor-Cell-Derived Cre+ EVs
In Vivo
Next, we used the Cre-LoxP system to investigate the in vivo ex-
istence of cell-to-cell transfer of mRNA and other biomolecules1048 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorsin different mammary and melanoma
tumor models (Figures 4 and S1). We
confirmed that EVs isolated from Cre+
tumors contained Cre mRNA (Figure 4A).
Next, we pretreated these EVs with
RNase and proteinase K (to degrade
free-floating Cre RNA and Cre protein)
and showed that, upon intratumoral
injection, reporter+ cells take up these
EVs and report Cre activity (Figure 4B).
Thus, cells only report vesicular Cre,
which is further supported by our obser-
vation that cells do not report the uptake
of free-floating Cre upon injection of
recombinant Cre protein (Figure 4C) orwhole-cell lysate of a Cre+ tumor (Figure 4D). Interestingly,
similar to our in vitro observations, in all mammary and mela-
noma tumor models that we studied, eGFP+ reporter+ cells
(negative for CFP [Figure S2]) appeared in tumors consisting of
Cre+ cells and reporter+ cells (Figure 4E and see Movie S5 for
a 3D reconstruction of a z stack of intravital images). Combined,
these data suggest that in vivo tumor cells can release and take
up EVs and that the functional mRNA transfer via EVs can be
reported by the Cre-LoxP system.
Figure 2. The Cre-LoxP System to Measure
EV Uptake
(A) Cartoon showing the Cre-LoxP system used to
report the transfer of Cre recombinase (Cre) ac-
tivity. A red-to-green color switch is induced in
reporter+ cells (right) upon the transfer of Cre ac-
tivity derived from CFP+ Cre+ cells (left).
(B) Electron microscopy analysis of EVs isolated
from MDA-MB-231 cell cultures. Scale bar repre-
sents 150 nm.
(C) NanoSight particle analysis displaying the
size distribution of EVs isolated from MDA-MB-
231 cell cultures. Black line represents mean of
five experiments, SD in gray.
(D) Confocal images of reporter+ cells that have
taken up green-labeled MDA-MB-231-isolated
EVs 3 hr after addition of these EVs to the culture.
The boxed area is shown on below the image.
Arrow points to EVs that are taken up. Scale bars
represent 50 mm.
(E and F) Characterization of EVs isolated from
MDA-MB-231 conditioned media (CM) using high-
speed centrifugation. The supernatant (sup) ob-
tained during this centrifugation procedure was
used as negative control in (E) western blot anal-
ysis of CD63, Hsp70, and Cre protein levels and (F)
RT-PCR for Cre mRNA of samples as indicated.
See also Movie S4.EV Exchange between Tumor Cells and Non-Tumor Cell
Types
Our Cre-Lox reporter enables us to study the uptake of EVs
released by defined populations of cells. Therefore, in our in vivo
syngeneic melanoma tumor model, we tested whether different
types of non-tumor cells take up tumor-released EVs and
whether tumor cells can take up EVs released from non-tumor
cells. We generated Cre-expressing B16 melanoma cells andCell 161, 1046–105injected these cells into mice ubiqui-
tously expressing the Cre-LoxP reporter
tdTomato (tdTomatoB6mice) (Figure 5A).
Within 2 weeks, these mice developed
palpable tumors, and we examined
various tissues for the presence of
different types of non-tumor cells that
report the uptake of Cre (i.e., tdTomato
expression). Interestingly, we observed
non-tumor cells expressing tdTomato in
all examined tissues (tumors, lymph no-
des, lungs, and spleens) (Figure 5B). To
investigate the nature of these cells, we
analyzed the expression of different
markers, including CD45, which is a gen-
eral immune cell marker. Interestingly, we
observed CD45 and CD45+ cells, sug-
gesting that both non-immune cells and
immune cells have taken up tumor-
released EVs (Figure 5C). By immunohis-
tochemistry, we identified various cell
types, including Gr1+ cells and F4/80+cells, suggesting the transfer of tumor-released EVs to neutro-
phils and macrophages (Figure 5D). From this, we conclude
that not only tumor cells but also multiple non-tumor cell types
are able to take up tumor cell-released EVs.
To test whether tumor cells can take up EVs released from
non-tumor cells, we generated B16melanoma cells that express
the Cre-LoxP reporter as shown in Figure 2A. Next, we injected
these reporter cells into B6 mice in which Cre is ubiquitously7, May 21, 2015 ª2015 The Authors 1049
Figure 3. In Vitro Visualization of Transfer of
Cre Activity
(A) Images of MDA-MB-231 cultures consisting of
reporter+ cells (red) only or a mixture of Cre+ (cyan)
and reporter+ cells. Note the appearance of eGFP+
reporter+ cells in the presence of Cre+ cells, indi-
cated by asterisks. Scale bars represent 50 mm.
(B) Quantification of the percentage of eGFP+
MDA-MB-231 cells in several conditions with
varying ratios of Cre+ and reporter+ cells (n = 5
independent experiments). Data are represented
as mean ± SEM.
(C) For 50 cells, the mean fluorescence intensity
(MFI) of eGFP (reporting Cre activity) is plotted
against the MFI of CFP (Cre+ cells). Intensities of
non-fluorescent cells are zero (red dot). In the left
plot, cell fusion was experimentally simulated by
transfecting eGFP+ cells with CFP DNA. In the
middle plot, communication was experimentally
simulated by transfecting reporter+ cells with Cre
DNA. The right plot shows the results of the
experimental co-culture. The blue dotted line
outlines cells that show cell fusion, and the green
dotted line shows eGFP expression derived from
cell-cell communication other than fusion.
(D) Images of MDA-MB-231 reporter+ cells (left),
T47D reporter+ cells (middle), or MCF-7 reporter+
cells (right) at the bottomwell of a transwell system
in the absence (upper images) or presence (lower
images) of MDA-MB-231 Cre+ cells in the upper
well (n = 3 independent experiments). Bar graphs
below show quantifications. Data are represented
as mean ± SEM. Scale bars represent 50 mm.
(E) Quantification of T47D cells (upper graph) and
MCF-7 cells (lower graph) that express eGFP in
several conditions with varying ratios of Cre+ and
reporter+ cells (n = 5 independent experiments).
Data are represented as mean ± SEM.expressed by the ACTB promoter (Figure 5E). Within 2 weeks,
these mice developed palpable tumors that we examined for
the presence of tumor cells reporting the uptake of EVs released
by Cre-expressing non-tumor cells. Only occasionally (2 ± 0.7
cells per mm3; n = 3 mice), we observed tumor cells that report
the uptake of EVs released from non-tumor cells (Figure 5F).
This observation is in line with the general assumption that
non-tumor cells release relatively less EVs compared to tumor1050 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorscells (Balaj et al., 2011; Raposo
and Stoorvogel, 2013). From this, we
conclude that, although B16 melanoma
cells have the ability to take up EVs
from healthy cells, this transfer does not
seem to happen frequently.
The Local and Systemic Transfer of
MDA-MB-231-Derived EVs to Less
Malignant T47D Cells
Because tumor cells can take up EVs
released by other tumor cells, we ques-
tioned whether less malignant tumor cells
can take up EVs derived from malignanttumor cells by analyzing tumors of mice injected with a mixture
of malignant MDA-MB-231 Cre+ cells and less malignant T47D
reporter+ cells (Figure 6A, left). While the T47D cells outcom-
peted the MDA-MB-231 cells to some extent, the percentage
of MDA-MB-231 cells in MDA-MB-231/T47D tumors was suffi-
cient to observe local transfer of Cre activity between these
cell types (Figure 6B, left). Next, we tested the possibility of sys-
temic transfer of Cre activity by injectingMDA-MB-231Cre+ cells
Figure 4. The Transfer of EVs between
Tumor Cells in Living Mice
(A) Cells and EVs were isolated from Cre+ tumors
and Cre tumors. Shown is the RT-PCR of indi-
cated samples.
(B) EVs isolated from Cre+ MDA-MB-231 cells and
pretreated with RNase and proteinase K (protK)
were intratumorally injected in T47D reporter+ tu-
mors. Shown are representative images of these
tumors and quantification of eGFP+ cells (n = 3
mice). Data are represented as mean ± SEM.
Scale bars represent 50 mm.
(C) Recombinant Cre protein (110 ng) was intra-
tumorally injected in T47D reporter+ tumors.
Shown are representative images of these tumors
and quantification of eGFP+ cells (n = 4mice). Data
are represented as mean ± SEM. Scale bars
represent 50 mm.
(D) Whole-cell lysate of 10% of a Cre+ MDA-MB-
231 tumor was intratumorally injected in T47D
reporter+ tumors. Shown are representative im-
ages of these tumors and quantification of eGFP+
cells (n = 4 mice). Data are represented as mean ±
SEM. Scale bars represent 50 mm.
(E) Confocal images of tumors containing only
reporter+ cells in control animals (negative control)
and in tumors that contain Cre+ cells and reporter+
cells. MDA-MB-231 mammary tumor (260 ± 67
eGFP+ tumor cells per intravital 620 3 620 3
100 mm z stack, n = 3 mice [for 3D reconstruction
see Movie S5]), T47D mammary tumor (513 ± 66
eGFP+ tumor cells per 16-mm-thick tumor section,
n = 3 mice), PyMT mammary tumor (30 ± 13
confetti+ tumor cells per 20 -mm-thick tumor sec-
tion, n = 3 mice), and B16 melanoma (43 ± 10
eGFP+ tumor cells per 100-mm-thick tumor sec-
tion, n = 3 mice). For the PyMT model, the Cre-
confetti-reporter system was used (see Figures
S1B and S1C; all colors are shown in green). Scale
bars represent 50 mm.
See also Movie S5 and Figures S1 and S2.and T47D reporter+ cells in contralateral mammary glands (Fig-
ure 6A, right). We observed that T47D cells reported Cre activity
derived from MDA-MB-231 Cre+ cells even when injected in
contralateral tumors (Figure 6B, right). As expected, systemic
transfer of Cre activity was less efficient than local transfer (Fig-
ure 6C). However, the observed efficiency in local transfer pre-
sumably represents an underestimation of the actual transfer
because Cre-reporting efficiency depends on the ratio of Cre+Cell 161, 1046–105over reporter+ cells (Figures 3B and
3E), which was 20 to 100 times smaller
in the local communication experiment
compared to the distant communication
experiment. In addition, the observed
efficiency in systemic transfer may be
slightly over-represented by a few Cre
cells that have migrated toward this
distant area (reseeding) and thereby
potentially transfer EVs locally (23 ± 10
cells per mm3, n = 3 mice). However,the number of reseeded Cre+ cells is negligible compared to
the total number of EV-producing Cre+ cells present at the
contralateral side. To confirm the distant EV transfer in a less
aggressive tumor model in which reseeding events are less
likely, we analyzed contralateral MCF-7 Cre+ and T47D reporter+
tumors (Figure S3). In this model, we did not observe any Cre+
MCF-7 cells in the contralateral T47D reporter+ tumors (n = 4
mice), whereas T47D reporter+ cells report the uptake of EVs7, May 21, 2015 ª2015 The Authors 1051
Figure 5. Transfer of EVs between Tumor
and Healthy Cells in Living Mice
(A) B16 melanoma CFP+ Cre+ cells were in-
jected subcutaneously in Cre reporter B6 mice
ubiquitously expressing a floxed-STOP-floxed-
tdTomato (R26-LSL-tdTomato mice).
(B) Representative confocal images (n = 3 mice)
showing tdTomato+ cells in indicated tissues (tu-
mors 374 ± 76 cells/mm3, lungs 69 ± 17 cells/
mm3, lymph nodes (LNs) 168 ± 69 cells/mm3,
spleens 104 ± 22 cells/mm3). CFP is indicated in
cyan, tdTomato is indicated in red, and DAPI is
indicated in blue. Scale bars represent 50 mm. All
numbers represent mean ± SEM.
(C) Confocal images of CD45+ (top images) and
CD45 tdTomato+ (bottom images) cells found in
the mice described in (A). Boxed areas are shown
on the right. CD45 staining is indicated in yellow,
tdTomato is indicated in red, CFP is indicated in
cyan, and DAPI is indicated in blue. Scale bars
represent 25 mm.
(D) Confocal images show Gr1+ cells (top images)
and F4/80+ tdTomato+ (bottom images) cells
found in themice described in (A). Boxed areas are
shown on the right. Gr1(top) and F4/80 (bottom)
stainings are indicated in yellow, tdTomato is
indicated in red, CFP is indicated in cyan, and
DAPI is indicated in blue. Scale bars represent
25 mm.
(E) B16 melanoma reporter+ cells were injected
subcutaneously in B6 ACTB-Cre mice that ex-
press Cre ubiquitously.
(F) Tumors were isolated from ACTB-Cre mice
bearing B16 melanoma reporter+ tumors (n = 3
mice). Representative confocal images show
eGFP+ melanoma cells (2.5 ± 0.6 cells/mm3).
Scale bars represent 50 mm. All numbers represent
mean ± SEM.released by the MCF-7 cells located at the contralateral side
(Figure S3A). Thus, both in in vitro culture models and in living
mice, tumor cells release and exchange functional biomolecules
(e.g., Cre) locally and systemically through EVs.
Migration of T47D Cells Is Enhanced upon Uptake of
MDA-MB-231-Derived EVs
Because we found mRNAs from many genes involved in migra-
tion and metastasis in MDA-MB-231-isolated EVs (Figure 1F)
and in vitro data haveshown thatmRNAcanbe functionally trans-
ferred to other cells (Valadi et al., 2007) (as we confirmed in vivo
for Cre), we investigated whether these EVs can affect themigra-1052 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorstory behavior of T47D recipient cells
in vivo. We intravitally imaged T47D cells
that reported (eGFP+) or did not report
(DsRed+) the local or distant transfer of
Cre activity (Figure 6A). We tracked the
migration of all individual eGFP+ cells
and randomly picked proximate DsRed+
cells within the same imaging field (Fig-
ure 6D) andmeasured the average migra-
tion speed of these cells per imaging field(Figure 6E, the values of measurements of eGFP+ and DsRed+
cells within the same imaging field are connected with a line). In
agreement with intravital observations by others (Condeelis and
Segall, 2003; Joyce and Pollard, 2009; Ellenbroek and van Rhee-
nen, 2014), migration varied among the different imaging fields
and mice, presumably caused by diverse microenvironments
(Figures 6E and 6F). The proximate presence of MDA-MB-231
cells favored a migration-inducing microenvironment for T47D
cells because both eGFP+ and DsRed+ T47D reporter+ cells
migrated fasterwhenMDA-MB-231were in close proximity (local
communication; Figure 6E) than when MDA-MB-231 cells were
located in a distant tumor (distant communication; Figure 6F).
Figure 6. Less Malignant T47D Cells that Take Up MDA-MB-231 EVs Display Enhanced Migration
(A) MDA-MB-231 CFP+ Cre+ cells and T47D reporter+ cells were injected as a mixture in one mammary gland (local communication) or separately in contralateral
mammary glands (distant communication).
(B) Representative intravital images of the tumors in mice as indicated. Scale bars represent 50 mm.
(C)QuantificationofeGFP+cells in the localanddistant communicationexperiments (n=26 frozen tumorsections from3mice).Dataare representedasmean±SEM.
(D) Mammary tumors containing MDA-MB-231 Cre+ cells and T47D reporter+ cells were intravitally imaged for 3 hr. Shown are migration paths of MDA-MB-231
cells and T47D DsRed+ (left) and eGFP+ reporter cells (right) within the same imaging field. In the far right, the migration speed of the same cells is plotted. Red
lines indicate means (n > 25 cells).
(E and F) The in vivomigration speed of T47D eGFP+ and DsRed+ reporter+ cells in tumors that report local (E) or distant (F) transfer of Cre fromMDA-MB-231 Cre+
cells. Shown are the average values per imaging field. Values for eGFP+ and DsRed+ cells in the same imaging field are connected with a line (n = 5–6 imaging
fields per mouse for 3 independent mice).
(G and H) The normalized in vivo migration speed of T47D eGFP+ and DsRed+ reporter+ cells in tumors reporting the local (G) or distant (H) transfer of Cre from
MDA-MB-231Cre+ cells. Per imaging field, the values are normalized to themigration speed of neighboring DsRed+ cells (n = 17–18 imaging fields in 3mice). Data
are represented as mean ± SEM.
See also Figures S3, S4, and S5.In order to test how the transfer of biomolecules, as reported
by our Cre reporter, affects migration within one space-confined
microenvironment, we compared the migration of eGFP+ andDsRed+ cells within one imaging field. Because the eGFP+ and
DsRed+ cells experience the same microenvironment such as
cytokines within one imaging field, differential behavior betweenCell 161, 1046–1057, May 21, 2015 ª2015 The Authors 1053
eGFP+ and DsRed+ cells illustrates the effect of EV uptake. In all
18 distinct positions reporting local transfer (n = 3 mice) (Fig-
ure 6E) and in 15 of the 17 distinct positions reporting systemic
transfer (n = 3 mice) (Figure 6F), we observed that eGFP+ cells
are more migratory than neighboring DsRed+ cells. To quantify
this effect within the various microenvironments, we normalized
the migration distance of tumor cells to the average migration
path of DsRed+ cells that did not report Cre activity in each im-
aging field independently (Figures 6G and 6H). Over time, we
tracked the position of more than 360 cells per condition (n = 3
mice) and found that eGFP+ cellsmigrate 1.57± 0.084 (Figure 6G)
and 2.37 ± 0.431 (Figure 6H) times faster than the DsRed+ cells
after local and distant communication, respectively. Similar re-
sults were found in in vitro studies in which we imaged local
(co-culture) and distant (transwell) communication (Figures
S4A and S4B). The observed effects on migration were not due
to the expression of the different fluorophores because cells
that became eGFP+ upon transfection with a Cre-encoding
DNA plasmid did not migrate faster than DsRed+ cells (Fig-
ure S4C). Our data suggest that tumor cell migration is depen-
dent on non-systemic cues in the local microenvironment and
that this migration can be significantly enhanced by the uptake
of migration-associated mRNAs through EV transmission.
The correlation between Cre uptake and increased motility is
fully consistent with the migratory-inducing mRNA cargo that
we identified in MDA-MB-231-released EVs, unless motile cells
are somehow more prone to take up biomolecules than less-
motile cells. Several lines of evidence exclude the latter hypoth-
esis. First, within one cell line (MDA-MB-231), the fast-migratory
cells did not take up more fluorescently labeled EVs than
slow-migratory cells (Figure S5A). Second, if motile cells would
have a higher a priori propensity to report Cre activity, then
eGFP+ cells would always migrate faster than DsRed+ cells,
which was not observed when comparing the migration speed
of eGFP+ and DsRed+ cells across different imaging fields (Fig-
ures 6E and 6F). Third, the percentage of cells that report
Cre was not increased in imaging fields with migratory-support-
ing microenvironments where faster average migration was
observed (Figure S5B). Fourth, the uptake of EVs produced by
a less migratory cell line (MCF-7) (Figure S3B) did not lead to
enhanced migration of eGFP+ cells; instead, we observed a sig-
nificant decrease in migration (Figure S3C). Therefore, our data
collectively show that migration of T47D cells is enhanced
upon the uptake of EVs released by MDA-MB-231 cells.
T47D Cells that Take Up MDA-MB-231 EVs Become
More Metastatic
Because activating migration and invasion is one of the hall-
marks of cancer (Hanahan and Weinberg, 2000, 2011) and key
to metastasis (Nguyen et al., 2009), the transfer of biomolecules,
including mRNAs involved in migration, may affect not only the
migratory behavior but also the metastatic potential of tumor
cells. To investigate this, we isolated the lungs of four mice
and analyzed in total >1,000 metastases (Figure 7A). When the
potential to metastasize to the lungs is enhanced by EV uptake
in the population of cells that report Cre activity (eGFP+), the ratio
of eGFP+ over DsRed+ cells that arrive and grow out in the lung is
expected to be increased compared to the ratio of these popu-1054 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorslations of cells in the corresponding primary tumor (Figure 7A).
As expected, T47D cells that take up EVs released by lessmigra-
tory MCF-7 cells (Figure S3B) did not show an increase in meta-
static potential (Figure S3D). Strikingly, when we analyzed the
lungs and corresponding primary tumors of malignant MDA-
MB-231 and less malignant T47D cells (Figures 7B and 7C), we
observed that T47D cells that take up EVs released by the
more malignant MDA-MB-231 cells showed a 52-fold increase
in metastatic potential (i.e., 52-fold increase in the eGFP+ over
DsRed+ ratio in lungs compared to the ratio in corresponding
primary tumors) upon local communication (Figure 7B) and a
7.9-fold increase upon distant communication (Figure 7C). In
addition to the less malignant T47D cells, MDA-MB-231 them-
selves also showed enhanced migration and metastasis upon
uptake of EVs released by MDA-MB-231 cells (Figure S6), which
is not surprising because mRNAs involved in metastasis were
specifically loaded and enriched in EVs, and therefore, cells
that take up these EVs are exposed to higher levels of mRNAs
involved in metastasis. These data combined suggest that the
uptake of these vesicular mRNA molecules boosts both migra-
tion and metastatic potential of tumor cells.
Concluding Remarks
In this manuscript, we presented a technique to visualize EV
transfer between tumor cells both in vitro and in living mice
based on the Cre-LoxP system and study the physiological ef-
fects of this transfer. Others have tried to study the functional
role of EV-mediated cell-cell communication in vivo by inhibiting
multivesicular body-related EV pathways in order to render cells
vesiculation deficient. However, this only led to a partial reduc-
tion in EV production (Bobrie et al., 2012; Peinado et al., 2012),
probably because EV shedding from the plasma membrane
was unaffected. More importantly, manipulating the EV-produc-
ing cells, by any means, may not only affect EV production, but
also EV-independent factors (e.g., the cytokine profile of donor
cells as observed for osteopontin, PIGF-2, PDGF-AA [Peinado
et al., 2012]) with EV-independent effects on migration and
metastasis of recipients cells. We took an alternative and reverse
approach by using the Cre-LoxP system where the behavior
of eGFP+ tumor cells (i.e., that have taken up tumor-EVs) is
compared to the behavior of DsRed+ tumor cells. The observed
differential behavior illustrates how uptake of EVs released from
Cre+ cells affects recipient cells without the requirement to
manipulate EV-releasing cells. An additional advantage of the
Cre-LoxP system is that it allows detection of uptake of only
the EVs released from an a priori defined cell population. Using
this method, we showed directional transfer of biomolecules be-
tween tumor cells and also between tumor and non-tumor cells
(Figure 5). The latter observation is in line with previous findings
that bone-marrow-derived cells that take up EVs can promote
metastatic niche formation (Peinado et al., 2012).
As with any technique, the Cre-LoxP system also has down-
sides. First, a small fraction of the Cre exchange that we de-
tected may have occurred via EV-independent mechanisms,
despite that we excluded cell-cell fusion and Cre transfer
through direct cell-cell contact and despite that we observed
only color switching upon intratumoral injection of purified Cre+
EVs and not upon injection of non-vesicular free Cre. Second,
Figure 7. Uptake ofMDA-MB-231-Released
EVs by T47D Cells Leads to Increased
Metastatic Potential
(A) MDA-MB-231 CFP+ Cre+ cells and T47D re-
porter+ cells were injected as a mixture in one
mammary gland (local communication) or sepa-
rately in contralateral mammary glands (distant
communication). The lungs and corresponding
primary reporter tumors were analyzed, and the
ratio of GFP+/DsRed+ metastases and cells was
determined. If EV uptake results in an enhanced
metastatic potential, the ratio of eGFP+ over
DsRed+ cells that arrive and grow out in the lung
is expected to be higher than the ratio of these
populations of cells in the primary tumor.
(B and C) Representative images of frozen sec-
tions of the primary tumor and lungs of mice of
local (B) and distant communication experiments
(C). Right dot plots show the fold increase
of metastatic potential (increase in eGFP+ over
DsRed+ ratio in lungs compared to the ratio in
corresponding primary tumors). Red lines show
the median, each symbol represents one cry-
osection, and different symbols represent different
mice (n = 4 mice per condition). Scale bars
represent 50 mm.
See also Figures S3 and S6.the functional transfer of Cre does not identify the exact func-
tional biomolecules that are transferred. Although we found a
set of enriched mRNAs of genes involved in migration and
metastasis, our Cre-LoxP system only reports EV uptake and
does not specify transfer of any type of functional biomolecules
such as DNA, (signaling) proteins, lipids, and microRNAs.
We found the mRNA of >200 genes to be vesicular enriched
compared to the MDA-MB-231 cells that release these EVs.
The enrichment of these biomolecules can be explained by spe-
cific loading (e.g., Villarroya-Beltri et al., 2013) or by non-specific
loading of biomolecules located at peripheral cell region in EVs
that are released at the edge of cells. The transfer of metastatic
capacity as reported by our Cre-LoxP system is therefore likely
to be caused by the transfer of multiple specifically and non-spe-
cifically loaded functional biomolecules, such as DNA, (signaling)
proteins, lipids, microRNAs, and mRNAs that concertedly affect
the multiple parallel migration and metastasis pathways. The
molecules responsible for phenotypic switches in recipient cells
cannot be generalized; different recipient cell types with expres-
sion profiles that differ from the EV-producing cells may also get
affected by biomolecules that are abundantly present but not
necessarily enriched in EVs. Therefore, the vesicular mRNA
from the genes listed in Figure 1F affect MDA-MB-231 cells,Cell 161, 1046–105whereas mRNA from yet another set of
genes loaded in the same EVs may alter
the behavior of other cell types.
Our study provides evidence in the
physiological context of heterogeneous
tumors insidewhole organisms that tumor
cells take up in-vivo-released tumor EVs.
The provided proof here for the existenceofEV transfer between tumor cellswitha role in tumorprogression
is supported by in vitro studies (Al-Nedawi et al., 2008; Demory
Beckler et al., 2013; Higginbotham et al., 2011; O’Brien et al.,
2013; Skog et al., 2008). We demonstrate, in livingmice, that ma-
lignant tumor cells, through transferofEVs, enhance themigratory
behavior and metastatic capacity of less malignant cells. These
data exemplify that tumor heterogeneity is much more complex
than currently anticipated, which has profound consequences
for our ideas on the mechanisms of tumor progression and for
designing optimal treatment strategies. EV-mediated long-range
cell-cell communication could indicate that metastasized cells
may influence the metastatic capacity of less malignant tumor
cells in the primary tumor and that tumor cells that have acquired
resistance to chemotherapymay influence the therapy resistance
of other tumor cells. However, more detailed future studies are
required, especially in a clinical setting, before the full magnitude
and clinical implications of our observations can be revealed.EXPERIMENTAL PROCEDURES
Intravital Imaging
Mice were sedated using isoflurane inhalation anesthesia (1.5% to 2% iso-
flurane/O2 mixture). The imaging site was surgically exposed, and the mouse7, May 21, 2015 ª2015 The Authors 1055
was placed with its head in a facemask within a custom-designed imaging
box. The isoflurane was introduced through the facemask and ventilated
by an outlet on the other side of the box. The imaging box and microscope
were kept at 36.5C by a climate chamber that surrounds the whole stage
of the microscope, including the objectives. Imaging was performed on
an inverted Leica TCS SP5 AOBS multi-photon microscope (Mannheim,
Germany) with a chameleon Ti:Sapphire pumped Optical Parametric Oscil-
lator (Coherent Inc.). The microscope is equipped with four non-descanned
detectors: NDD1 (<455 nm), NDD2 (455–490 nm), NDD3 (500–550 nm),
and NDD4 (560–650 nm). Different wavelengths between 700 nm and
1,150 nm were used for excitation; CFP was excited with a wavelength of
840 nm, and GFP and DsRed were excited with a wavelength of 960 nm.
CFP was detected in NND2, GFP was detected in NDD3, and DsRed was
detected in NDD4. All images were in 12 bit and acquired with a 253
(HCX IRAPO N.A. 0.95 WD 2.5 mm) water objective. All pictures were pro-
cessed using ImageJ software; pictures were converted to an 8 bit RGB,
smoothed (if necessary), cropped (if necessary), rotated (if necessary), and
contrasted linearly.
Tracking Migration of Tumor Cells
The eGFP and DsRed images of tumors were acquired in living mice using our
multi-photon microscope. Individual DsRed+ and eGFP+ cells can be recog-
nized equally well, and migration differences caused by detection differences
can thus be excluded. Three-dimensional volumes (z stacks) were collected,
and the images were stored on the hard-disk for analysis. Images were cor-
rected for XYZ-drift using custom-made software. Cells were trackedmanually
with an ImageJ plugin (‘‘Manual Tracking’’ Rasband, W.S., ImageJ, U.S. NIH;
http://imagej.nih.gov/ij/). At the beginning of each movie, a random DsRed+
cell close to an eGFP+ cell was selected. The XY position was determined
over time, and the displacement and track distance were calculated by Excel
(Microsoft).
Analyzing Metastatic Capacity of Tumor Cells
Cryosections (150 mm thick) of tumors and lungs were prepared and imaged
as described in the Extended Experimental Procedures section ‘‘Immunos-
tainings and Confocal Microscopy of Tissue Sections.’’ The images were
coded randomly by one investigator, and the images were blinded analyzed
by two independent researchers that did not know the experimental condi-
tions. Tile scans of tumors were analyzed using ImageJ; a binary threshold
was set separately for the red and green channels, the number of pixels
above the threshold (being positive for either red or green) was measured,
and the ratio eGFP/DsRed was determined. Tile scans of lungs were
analyzed in LAS-AF; the amount of DsRed+ and eGFP+ metastases was
counted manually, and the ratio eGFP/DsRed was determined. We classified
metastases into two categories; metastases that were entirely DsRed+ and
metastases that were entirely eGFP+. Only a few metastases (< 2.5%) were
multicolored and therefore excluded from our analysis. Metastatic potential
is calculated by dividing the ratio of eGFP+ over DsRed+ cells that arrive
and grow out in the lung by the ratio of these populations of cells in the
primary tumor.
Gene Expression Analysis
Total RNA was isolated from cells and EVs using the TRIZOL reagent accord-
ing to the manufacturer’s instructions (Invitrogen) and quantified using
a ND1000 spectrophotometer (Nanodrop Technologies). The quality control,
RNA labeling, hybridization, and data extraction were performed at
ServiceXS B.V. The RNA quality and integrity were determined using Lab-
on-Chip analysis on the Agilent 2100 Bioanalyzer (Agilent Technologies,
Inc.). Biotinylated cRNA was prepared using the Illumina TotalPrep RNA
Amplification Kit (Ambion, Inc.) according to the manufacturer’s specifica-
tions with an input of 200 ng total RNA. Per sample, 750 ng of the obtained
biotinylated cRNA samples was hybridized onto the Illumina HumanHT-12 v4
(Illumina, Inc.). Each BeadChip contains 12 arrays. Hybridization and washing
were performed according to the Illumina Manual ‘‘Direct Hybridization Assay
Guide.’’ Scanning was performed on the Illumina iScan (Illumina, Inc.). Image
analysis and extraction of raw expression data were performed with Illumina
GenomeStudio v2011.1 Gene Expression software with default settings (no1056 Cell 161, 1046–1057, May 21, 2015 ª2015 The Authorsbackground subtraction and no normalization). Primary gene expression
analysis of the scanned BeadChip arrays was performed using Illumina’s
GenomeStudio v.2011.1 software with the default settings advised by Illu-
mina. The data were analyzed with the R/Bioconductor package limma
(Wang et al., 2013). To remove non-linear hybridization artifacts, we first
performed loess normalization. Next, we combined replicates to calculate
p values for differential expression. Finally, we took a 2-fold cut-off to select
only the most strongly enriched RNAs in the vesicles compared to whole-cell
RNA. The set of enriched genes was analyzed using the WebGestalt tool for
functional classification. The set of enriched RNAs was used as the input set;
the genes present on the array were used as a background set. The data dis-
cussed in this publication have been deposited in NCBI’s Gene Expression
Omnibus (Edgar et al., 2002) and are accessible through GEO series acces-
sion number GEO: GSE66488 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE66488).
Statistical Analyses
For all normal distributed measurements, the Student’s t test was used to
determine whether there was a significant difference between two means
(p < 0.05), and for all others the Mann-Whitney U test was used. Significance
is marked with one asterisk when the p value is equal to or smaller than 0.05,
and with two asterisks when the p value is equal to or smaller than 0.01.
Supplemental Experimental Procedures are available in the Supplemental
Information section.
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